Québec City, Canada, December 4, 2008 – Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ), a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that its President and CEO, Juergen Engel, Ph.D., will take part in a panel discussion titled, “Replacing The Mainstay With Newer And Better Agents” at the upcoming RBC Capital Markets 2008 Healthcare Conference on Wednesday, December 10, 2008 at 4:30 pm (eastern time) at the Westin Times Square Hotel in New York.
A live webcast of the presentation will be available on Æterna Zentaris’ website at www.aezsinc.com in the Investors section. A replay will also be available for a period of 30 days on the Company’s website.
About Æterna Zentaris Inc.
Æterna Zentaris Inc. is global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.
